As investors weighed the stimulus vote of Monday against the emergence of a new coronavirus strain in the UK, US equities ended mixed on Tuesday.
Alterity Therapeutics Limited (ATHE) stock plunged -10.31% to $2.0 in the pre-market trading after the company announced the approval of a US patent for the
FuelCell Energy Inc. (FCEL) stock soared 7.34% to $4.02 in the pre-market trading. The most recent rating by JP Morgan, on October 08, 2020, is
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.